首页> 外国专利> PROCESS FOR THE PRODUCTION OF CAPSULAR POLYOSIDES,CAPSULAR POLYOSIDES OBTAINED THEREBY,AND THEIR APPLICATION TO THE PREPARATION OF VACCINES

PROCESS FOR THE PRODUCTION OF CAPSULAR POLYOSIDES,CAPSULAR POLYOSIDES OBTAINED THEREBY,AND THEIR APPLICATION TO THE PREPARATION OF VACCINES

机译:制备胶囊型磷脂的方法,由此获得的胶囊型多糖及其在制备疫苗中的应用

摘要

1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside. 1. Claims (for the Contracting State AT) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside.
机译:1.权利要求(对于缔约国:BE,CH,DE,FR,GB,IT,LI,LU,NL,SE)由包含其的被包埋细菌生产免疫原性荚膜多糖的方法,其特征在于其培养在合成培养基中的细菌,该培养基可能含有约0.5%重量的天然物质;在所述培养物的生长阶段结束时,除去微生物体,将除去微生物体后的液相通过膜过滤,该膜保留分子量为100000道尔顿以上的分子,从而得到荚膜富含多苷的保留材料;从所述保留的物质中除去蛋白质,核酸和脂质,得到纯化的荚膜多糖。 1.权利要求书(针对缔约国AT),由包含其的被包埋细菌生产免疫原性荚膜多苷的方法,其特征在于,其在于将细菌培养在合成培养基中,该合成培养基可包含最多约0.5重量%的天然存在的材料;在所述培养物的生长阶段结束时,除去微生物体,将除去微生物体后的液相通过膜过滤,该膜保留分子量为100000道尔顿以上的分子,从而得到荚膜富含多苷的保留材料;从所述保留的物质中除去蛋白质,核酸和脂质,得到纯化的荚膜多糖。

著录项

  • 公开/公告号IE53582B1

    专利类型

  • 公开/公告日1988-12-21

    原文格式PDF

  • 申请/专利权人 BERRI-BALZAC;

    申请/专利号IE19820001705

  • 发明设计人

    申请日1982-07-15

  • 分类号C12P19/04;A61K39/02;

  • 国家 IE

  • 入库时间 2022-08-22 06:39:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号